C. Castro

发表

Consenso sobre diagnóstico y tratamiento de Leucemia Mieloide Crónica en Colombia Consensus on diagnosis and treatment of Chronic Myeloid Leukemia in Colombia.

M. Rodríguez, A. Cardona, Leonardo Enciso, 2008 .

Recurrent pleomorphic anaplastic xanthoastrocytoma and response to combination of carmustine and bevacizumab, a case report

A. Cardona, S. Bermúdez, A. Ruíz-Patiño, 2018 .

Desorden linfoproliferativo CD20 negativo postras- plante hepático en remisión completa con rituximab CD20 negative posttransplant lymphoproliferative disorder after liver transplantation in complete remission with rituximab

C. Castro, A. Vera, H. Becerra, 2011 .

Genomic value of isocitrate-dehydrogenase (IDH1/2) in glioma origin and progression (ONCOLGroup)

C. Balañà, A. Cardona, L. Reveiz, 2010 .

Metastatic non-small cell lung cancer Current treatment based on evidence* (ONCOLGroup)

N. Reguart, A. Cardona, L. Reveiz, 2010 .

Tumores del estroma gastrointestinal (GIST): experiencia en dos instituciones hospitalarias de Bogotá D.C., Colombia (estudio del ONCOLGroup) Gastrointestinal stromal tumours (GIST): experience in two hospitals of Bogotá D.C., Colombia (ONCOLGroup study)

A. Cardona, L. Reveiz, É. Ospina, 2008 .

Current treatment based on evidence * (ONCOLGroup)

H. Carranza, C. Castro, S. Serrano, 2010 .

Survival of advanced lung adenocarcinoma patients and report of the first epidermal growth factor receptor mutations recognized in Colombia ONCOLGroup study

N. Reguart, A. Cardona, E. Carrasco, 2009 .

Gait disturbance after hepatic trasplantation

C. Castro, G. Quintero, N. Useche, 2011 .

Prognostic value of microvascular density and expression of VEGF, EGFR and HIF-1α in patients with locally advanced cervical cancer treated with chemoradiation (ONCOLGroup)§

A. Cardona, L. Reveiz, Á. Muñoz, 2012 .

Distribution and impact of research in hematology and oncology in Latin America (LATAM): A decade of uncertainty (ONCOLGroup).

L. Reveiz, C. Vargas, J. Otero, 2012 .

Screening for mutations in Colombian metastatic non-small cell lung cancer (NSCLC) patients (ONCOLGroup).

A. Cardona, A. Jiménez, R. Duarte, 2011, Journal of Clinical Oncology.